Cara Therapeutics Inc (NASDAQ:CARA) Director Sells $64,575.00 in Stock

  • Summary:


    Cara Therapeutics Inc (NASDAQ:CARA) Director Jeffrey L. Ives sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $25.83, for a total value of $64,575.00. Following the completion of the sale, the director now directly owns 8,500 shares of the company’s stock, valued at $219,555. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

    NASDAQ:CARA traded up $0.10 during mid-day trading on Wednesday, hitting $17.03. 2,483,305 shares of the stock were exchanged, compared to its average volume of 725,814. The stock has a market capitalization of $1.04 billion, a price-to-earnings ratio of -8.27 and a beta of 2.30. The fi ...



    Read Full News:

Log in to reply